Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Tissue Engineering & Bioprinting: Research to Commercialization

Jos Malda's Biography



Jos Malda, Professor of Biofabrication in Translational Regenerative Medicine, University Medical Centre Utrecht

Jos Malda is professor of Biofabrication in Translation Regenerative Medicine and Head of Research at the Department of Orthopaedics, University Medical Center Utrecht. He also has an appointment at the Department of Equine Sciences, University of Utrecht. He received his MSc degree in Bioprocess Engineering from Wageningen University in 1999 and completed PhD on Cartilage Tissue Engineering in 2003 (University of Twente). In 2007, Dr Malda was awarded a fellowship that allowed him to establish his research group in Utrecht, which focuses on biofabrication and biomaterials design, in particular for the regeneration of (osteo)chondral defects. He has published over 100 articles in peer-reviewed international journals, attracted significant national and international research funding and holds an ERC Consolidator grant. He is a long-standing Board member of the International Cartilage Repair Society (ICRS) and the current President of the International Society for Biofabrication (ISBF).

Jos Malda Image

Development of Bioinks for 3D-Bioprinting

Monday, 9 February 2015 at 16:00

Add to Calendar ▼2015-02-09 16:00:002015-02-09 17:00:00Europe/LondonDevelopment of Bioinks for 3D-BioprintingTissue Engineering and Bioprinting: Research to Commercialization in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com

Hydrogels are particularly attractive as “bioinks” for biofabrication as they recapitulate several features of the natural extracellular matrix and allow cell encapsulation in a highly hydrated mechanically supportive 3D environment. Additionally, they allow for efficient and homogeneous cell seeding, can provide biologically-relevant chemical and physical signals and can be formed in various shapes and biomechanical characteristics. Nevertheless, there exists a significant challenge in biofabrication: the optimization of – intrinsically weak – hydrogels to address the physico-chemical demands of the biofabrication process and the right conditions for cell survival on the one hand, and to address the harsh in vivo mechanical environment on the other. We have developed novel hydrogel-based bioink formulations that allow for the construction of intricate 3D structures, whilst providing the cells with a biologically suitable environment.


Add to Calendar ▼2015-02-09 00:00:002015-02-10 00:00:00Europe/LondonTissue Engineering and Bioprinting: Research to CommercializationTissue Engineering and Bioprinting: Research to Commercialization in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com